Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/19/2025

Sleep-Related Disorders

Risk Factors

  • Nasal obstruction due to septal deviation, nasal polyps, hypertrophied turbinates, chronic rhinitis, and nasal congestion is a common cause of snoring 1
  • Enlarged tonsils and adenoids, particularly in children, can contribute to snoring 2
  • A BMI >95th percentile for age and gender in children is associated with an increased risk of snoring 2
  • Higher prevalence of snoring is found in men (40% in adult men vs. 20% in adult women) 3
  • Allergic rhinitis can cause nasal congestion, leading to increased airway resistance and snoring 1

Associated Conditions

  • Snoring is often a symptom of obstructive sleep apnea (OSA) 3
  • Adenotonsillar hypertrophy is the primary cause of snoring in children 2
  • Children with habitual snoring may have neurocognitive impairment, behavioral problems, and failure to thrive 2

Diagnosis of Positional Obstructive Sleep Apnea (POSA)

  • The European Respiratory Society defines POSA as a condition where the apnea-hypopnea index (AHI) in the supine position is at least twice as high as the AHI in the non-supine position, with no relevant non-supine AHI (<15 events/hour) 4, 5
  • A minimum time spent in both supine and non-supine positions during sleep study (typically 30 minutes to 1 hour of sleep in each position) is required for accurate diagnosis 4
  • Approximately 50% of OSA patients have positional OSA, as reported by the European Respiratory Society 5

Treatment of Positional OSA

  • The European Respiratory Society suggests either vibratory positional therapy or CPAP for patients with mild or moderate position-dependent OSA with non-supine AHI <15 events/hour 4
  • For mild positional OSA, either vibrational positional therapy or mandibular advancement devices (MAD) may be used, as recommended by the European Respiratory Review 4
  • Positional therapy is not recommended for severe OSA or patients with significant non-supine AHI, as stated by the European Respiratory Review 4
  • CPAP remains the gold standard for moderate to severe OSA, as reported in Pulmonology 3
  • Positional therapy has fewer side effects compared to CPAP, as reported by the European Respiratory Review 4
  • Positional therapy has better compliance compared to CPAP, with an additional 2.5 hours per night, as stated by the European Respiratory Review 4

Management and Follow-up

  • If positional therapy is used, sleep studies should be performed to document individual success, as recommended by the European Respiratory Journal 5
  • Long-term compliance should be secured by follow-up studies, as stated by the European Respiratory Journal 5
  • Not all patients normalize AHI when non-supine, so correction of OSA by position should be documented with polysomnography before initiating this form of treatment, as noted by the Journal of Clinical Sleep Medicine 6
  • Elevation of the head of the bed may be used as a strategy to allow down-titration of EPAP pressure in patients using non-invasive positive pressure ventilation (NPPV) who find the pressure difficult to tolerate, as stated by the American Academy of Sleep Medicine 7
  • Positional therapy (avoiding the supine position) can be an effective secondary therapy for patients with positional OSA, as reported by the American Academy of Sleep Medicine 6
Treatment Indication Recommendation
Vibratory positional therapy Mild or moderate position-dependent OSA European Respiratory Society [4]
CPAP Moderate to severe OSA Pulmonology [3]
Mandibular advancement devices (MAD) Mild positional OSA European Respiratory Review [4]